IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet    (IPLB)

Just Released: The No. 1 Stock to Buy in 2020

Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 1,223.4
Mkt Cap Rs m 154,386
Vol '000 5.0
P/E X 25.8
P/CF X 24.7
EPS (TTM) Rs 47.4
% ch % -0.2
No. of shares m 126.20
% ch week % -0.8
% ch 1-mth % 6.2
% ch 12-mth % 56.3
52 week H/L Rs 1,263.9/718.0
(As on Jan 24, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs8998886436951,042 
Low Rs591629503400590 
Sales per share (Unadj.) Rs249.2230.3254.5260.2298.6 
Earnings per share (Unadj.) Rs20.17.615.419.035.0 
Diluted earnings per shareRs20.17.615.419.035.0 
Cash flow per share (Unadj.) Rs34.420.629.133.149.4 
Dividends per share (Unadj.) Rs1.0001.001.003.00 
Adj. dividends per shareRs1.000.001.001.003.00 
Dividend yield (eoy) %0.100.20.20.4 
Book value per share (Unadj.) Rs174.1179.0194.6213.0247.1 
Adj. book value per shareRs174.1179.0194.6213.0247.4 
Shares outstanding (eoy) m126.20126.20126.20126.20126.35 
Bonus/Rights/Conversions  ----ESOS 
Price / Sales ratio x3.03.32.32.12.7 
Avg P/E ratio x37.099.537.228.923.3 
P/CF ratio (eoy) x21.736.919.716.616.5 
Price / Book Value ratio x4.34.22.92.63.3 
Dividend payout %5.006.55.38.6 
Avg Mkt Cap Rs m94,05795,72372,30069,120103,108 
No. of employees `00013.013.113.313.313.4 
Total wages/salary Rs m5,6516,2566,9607,3597,874 
Avg. sales/employee Rs Th2,416.42,213.32,414.62,477.42,807.0 
Avg. wages/employee Rs Th434.3476.4523.2555.2585.8 
Avg. net profit/employee Rs Th195.473.3146.2180.6329.0 
IPCA LABS INCOME DATA
Net Sales Rs m31,44429,06532,12232,83637,732 
Other income Rs m327222210418577 
Total revenues Rs m31,77129,28732,33233,25438,309 
Gross profit Rs m5,3632,8964,3814,5056,901 
Depreciation Rs m1,7961,6331,7301,7771,824 
Interest Rs m284319241240189 
Profit before tax Rs m3,6111,1662,6212,9055,465 
Minority Interest Rs m00000 
Prior Period Items Rs m-490000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,0192046755111,042 
Profit after tax Rs m2,5429621,9452,3944,422 
Gross profit margin %17.110.013.613.718.3 
Effective tax rate %28.217.525.817.619.1 
Net profit margin %8.13.36.17.311.7 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m19,34816,21917,41819,45523,778 
Current liabilities Rs m12,5179,7009,55910,07610,975 
Net working cap to sales %21.722.424.528.633.9 
Current ratio x1.51.71.81.92.2 
Inventory Days Days10710510098104 
Debtors Days Days7356576766 
Net fixed assets Rs m20,54021,42920,77920,43520,368 
Share capital Rs m252252252252253 
"Free" reserves Rs m21,56422,57824,30026,63330,971 
Net worth Rs m21,96522,59224,55326,88631,224 
Long term debt Rs m4,9874,8433,5172,3401,409 
Total assets Rs m41,24838,91739,59541,17345,507 
Interest coverage x13.74.711.913.130.0 
Debt to equity ratio x0.20.20.10.10 
Sales to assets ratio x0.80.70.80.80.8 
Return on assets %6.93.35.56.410.1 
Return on equity %11.64.37.98.914.2 
Return on capital %14.35.410.210.817.3 
Exports to sales %52.949.248.647.645.9 
Imports to sales %16.715.314.214.916.6 
Exports (fob) Rs m16,62414,29915,61715,64217,308 
Imports (cif) Rs m5,2474,4454,5714,8846,266 
Fx inflow Rs m16,74914,29915,61715,64217,308 
Fx outflow Rs m6,9565,8224,5714,8846,266 
Net fx Rs m9,7938,47711,04610,75911,042 
IPCA LABS CASH FLOW
From Operations Rs m 4,682 7,087 2,819 3,411 4,923 
From Investments Rs m -6,893 -2,183 -1,488 -1,354 -1,563 
From Financial Activity Rs m 2,505 -4,615 -1,591 -1,304 -1,832 
Net Cashflow Rs m 294 288 -260 753 1,528 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 45.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.4%
FIIs 25.3%
ADR/GDR 0.0%
Free float 17.4%
Shareholders 36,892
Pledged promoter(s) holding 2.1%
 

Company Information

REGD OFF 48, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067
E-MAIL investors@ipca.com WEB www.ipca.com
TELEPHONE (022) 6647 4444 FAX (022) 2868 6613
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   PIRAMAL ENTERPRISES  NOVARTIS  FDC LTD.  STRIDES PHARMA SCIENCE  LUPIN  

Compare IPCA LABS With:   PIRAMAL ENTERPRISES  NOVARTIS  FDC LTD.  STRIDES PHARMA SCIENCE  LUPIN  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Buzz on the Street: A Look at Stocks, Sectors and the Economy(Podcast)

The stock markets in India remained rangebound this week. Economic data releases and third quarter results announcements were the focus of the week.

Views on news

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - ALEMBIC LTD COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS